David P. Faxon

Q: What Schools Are Affiliated With David P. Faxon

David P. Faxon is affiliated with the following schools: Boston University, Emory University, University of Kentucky, McMaster University, University of Southern California, University of Chicago, University of Pittsburgh, Harvard University

David P. Faxon's AcademicInfluence.com Rankings

David P. Faxon

Philosophy

#5585

World Rank

#8426

Historical Rank

Logic

#2838

World Rank

#3898

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David P. Faxon's Degrees

Doctorate Medicine Harvard University

Why Is David P. Faxon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David P. Faxon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients (2002) (3666)
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography (2006) (3207)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) (2963)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. (2002) (2786)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (2315)
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (2258)
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients (2002) (2245)
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (2001) (1865)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (1807)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (1569)
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). (2003) (1549)
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (1523)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (1467)
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (1407)
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (1400)
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) (1400)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (1373)
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). (1988) (1227)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (1224)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) (1200)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (1197)
Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. (1984) (1138)
ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. (1999) (1137)
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation (2007) (1064)
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent (2006) (1040)
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). (2000) (1029)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang (2006) (1006)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article (2002) (893)
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (880)
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemaker (2008) (866)
Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. (1988) (844)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial (2010) (808)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co (2003) (786)
Early versus delayed invasive intervention in acute coronary syndromes. (2009) (781)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (769)
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro (2001) (767)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing co (2003) (731)
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary (2001) (728)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (709)
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (618)
ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations (2000) (606)
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. (1996) (526)
Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1996) (493)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati (2002) (479)
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1990) (442)
ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and (1999) (418)
Complete Revascularization with Multivessel PCI for Myocardial Infarction. (2019) (399)
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angi (2008) (369)
Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. (1993) (366)
Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1988) (336)
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries (2000) (335)
Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. (1994) (326)
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. (1987) (325)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (315)
Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) (1998) (301)
A Taxonomy for Disease Management: A Scientific Statement From the American Heart Association Disease Management Taxonomy Writing Group (2006) (301)
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis (2013) (280)
Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS). (1982) (279)
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. (2002) (278)
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. (2004) (275)
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. (2007) (274)
Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention (2005) (258)
Angiotensin Converting Enzyme Inhibition in Patients with Congestive Heart Failure (1978) (252)
One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. (1989) (233)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) (2006) (226)
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril (1995) (226)
Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting (2011) (222)
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. (2003) (220)
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. (1979) (214)
Recommendation to Develop Strategies to Increase the Number of ST-Segment–Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention (2006) (210)
Acute Effects of Transluminal Angioplasty in Three Experimental Models of Atherosclerosis (1982) (209)
Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. (1986) (207)
Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. (2002) (205)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (204)
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women (2003) (203)
The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis. (1983) (203)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (202)
Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? (1995) (189)
Acute Regional Circulatory and Renal Hemodynamic Effects of Converting‐enzyme Inhibition in Patients with Congestive Heart Failure (1981) (188)
Low Molecular Weight Heparin in Prevention of Restenosis After Angioplasty: Results of Enoxaparin Restenosis (ERA) Trial (1994) (179)
Restenosis following transluminal angioplasty in experimental atherosclerosis. (1984) (174)
ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angio (2008) (173)
Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe. (1985) (172)
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention. (2018) (172)
Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. (1992) (170)
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. (2004) (158)
ACC/AHA Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery (2002) (152)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (151)
Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. (1984) (145)
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. (1985) (140)
Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS). (1982) (137)
Effect of antiplatelet therapy on restenosis after experimental angioplasty. (1984) (136)
Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. (1985) (134)
ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology. (1998) (126)
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. (2004) (123)
Percutaneous coronary laser thermal angioplasty. (1986) (119)
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive Summary (2011) (119)
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial (2005) (118)
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction [TIMI] II trial) (1993) (117)
Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. (1992) (113)
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. (2019) (111)
Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. (2001) (107)
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. (1981) (106)
Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. (1993) (106)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. (2002) (105)
Effects of Optimal Medical Treatment With or Without Coronary Revascularization on Angina and Subsequent Revascularizations in Patients With Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease (2011) (104)
Mechanism of angioplasty and its relation to restenosis. (1987) (103)
Results of coronary angioplasty of chronic total occlusions (the National Heart, Lung, and Blood Institute 1985-1986 Percutaneous Transluminal Angioplasty Registry). (1992) (103)
Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina. Report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Surgery Study Registries. (1984) (102)
Determinants of clinical response and survival in patients with congestive heart failure treated with captopril. (1982) (102)
Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the American College of Cardiology. (1998) (97)
Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). (2001) (93)
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. (1996) (90)
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. (2016) (89)
Remodeling of the coronary artery after vascular injury. (1997) (88)
The degree of revascularization and outcome after multivessel coronary angioplasty. (1992) (88)
Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. (2012) (87)
The influence of surgery on the natural history of angiographically documented left ventricular aneurysm: the Coronary Artery Surgery Study. (1986) (86)
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATO (1996) (84)
Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. (1987) (84)
ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis (2008) (83)
Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty. (1987) (83)
ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 199 (2007) (80)
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. (2009) (79)
Guidelines for the Management of Patients With Supraventricular Arrhythmias * — Executive Summary (2003) (78)
Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention (2003) (74)
Results of percutaneous transluminal coronary angioplasty in patients ≥65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry)☆ (1990) (74)
Present use of bedside right heart catheterization in patients with cardiac disease (1998) (73)
Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? (1998) (72)
Clinical studies on coronary revascularization in patients with type 2 diabetes. (2003) (72)
Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. (1991) (72)
Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. (2011) (71)
Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model. (1997) (68)
Outcome after major dissection during coronary angioplasty using the perfusion balloon catheter. (1991) (68)
The optimal management of patients on oral anticoagulation undergoing coronary artery stenting (2014) (67)
Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension. (1977) (67)
Task force 1: training in clinical cardiology. (2008) (65)
Transluminal Angioplasty in Experimental Atherosclerosis Analysis for Embolization Using an In Vivo Perfusion System (1982) (65)
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction (1995) (62)
Central and Peripheral Hemodynamic Effects of Angiotensin Inhibition in Patients with Refractory Congestive Heart Failure (1980) (62)
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update. (2021) (61)
Therapeutic and economic value of a normal coronary angiogram. (1982) (58)
Determinants of successful percutaneous transluminal coronary angioplasty: report from the National Heart, Lung, and Blood Institute Registry. (1984) (56)
Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. (2001) (55)
Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes. (2011) (55)
Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery. (2008) (52)
Systemic drug therapy for restenosis: "déjà vu all over again". (2002) (52)
The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease. (1982) (52)
Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial (2008) (50)
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993–1994 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry) (1997) (49)
Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplasty. (1992) (48)
Prevention of Post‐PTCA Restenosis (1994) (46)
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. (1982) (46)
Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1994) (46)
Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. (2003) (46)
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. (2013) (45)
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. (2008) (43)
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the Amer (2014) (41)
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. (2013) (41)
Guidelines for Percutaneous Transluminal Coronary Angioplasty (2005) (41)
Need for Centers to Care for Patients With Acute Coronary Syndromes (2003) (40)
American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus documents. (1999) (39)
Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II). (1992) (39)
Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization. The Balloon Angioplasty Revascularization Investigation (BARI). (2001) (39)
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) (2002) (38)
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 199 (2007) (35)
Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure. (1984) (35)
Follow-up of patients from the coronary artery surgery study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty. (1983) (34)
Payment for quality: guiding principles and recommendations: principles and recommendations from the American Heart Association's Reimbursement, Coverage, and Access Policy Development Workgroup. (2006) (34)
Has improvement in PTCA intervention affected long-term prognosis? The NHLBI PTCA Registry experience. (1995) (34)
Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty. (1989) (34)
The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry. (2006) (34)
Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. (2005) (33)
Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). (2011) (32)
Guidelines for training, credentialing, and maintenance of competence for the performance of coronary angioplasty: a report from the Interventional Cardiology Committee and the Training Program Standards Committee of the Society for Cardiac Angiography and Interventions. (1993) (32)
The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes). (2011) (32)
Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. (2015) (32)
Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril. (1985) (32)
Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Current State of ST-Elevation Myocardial Infarction Care (2007) (31)
Bringing reality to drug-eluting stents. (2004) (31)
Prolonged Clopidogrel Use After Bare Metal and Drug-Eluting Stent Placement: The Veterans Administration Drug-Eluting Stent Study (2012) (31)
Current advances in the diagnosis and treatment of renal artery stenosis. (2004) (31)
Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty. (1989) (31)
Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). (1995) (31)
Task force III: Training in cardiac catheterization (1986) (30)
Facts and controversies of aspirin and clopidogrel therapy. (2009) (28)
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. (2004) (27)
Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease (2015) (27)
Changing profiles of failed coronary angioplasty patients: impact on surgical results. (1992) (26)
Circulation: cardiovascular interventions: keeping pace with progress. (2008) (26)
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the Amer (2014) (26)
Very late stent thrombosis: current concepts (2012) (26)
Long-term outcome of patients after percutaneous transluminal coronary angioplasty. (1990) (25)
The changing face of interventional cardiology. (2012) (25)
National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry as a standard for comparison of new devices. When should we use it, and what should we compare? (1991) (24)
Left main coronary revascularization at the crossroads. (2006) (24)
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. (2017) (24)
Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients (2005) (24)
Balloon angioplasty significantly increases collagen content but does not alter collagen subtype I/III ratios in the atherosclerotic rabbit iliac model. (1996) (24)
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group. (1993) (24)
Interventional Cardiology: Current Status and Future Directions in Coronary Disease and Valvular Heart Disease. (2016) (23)
Angiotensin converting enzyme inhibition reduces restenosis in experimental angioplasty (1991) (23)
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. (1997) (23)
The chain of scientific discovery: the critical role of the physician-scientist. (2002) (23)
Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry). (1990) (22)
Arterial remodeling at the reference site after angioplasty in the atherosclerotic rabbit model. (1998) (22)
Hemodynamic rounds: Transvalvular pressure gradient measurement (2001) (22)
Clinics of CSI (1986) (21)
Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. (2017) (21)
American College of Cardiology / American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Prognosis of Coronary Artery Disease Committee Members (2000) (21)
Treatment of Chronic Orthostatic Hypotension with Ergotamine (1983) (20)
Use of percutaneous transluminal coronary angioplasty and bypass surgery despite improved medical therapy for unstable angina pectoris. (1988) (20)
Evaluation of a transitional care pharmacist intervention in a high‐risk cardiovascular patient population (2018) (20)
The risk of reperfusion strategies in the treatment of patients with acute myocardial infarction. (1988) (20)
Pacemaker Guidelines) Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 American College of Cardiology/American Heart Association Task Force on Pacemakers and Antiarrhythmia Devices: Summary Article : A Report of the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac (2006) (19)
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. (2017) (19)
Partnering to Reduce Risks and Improve Cardiovascular Outcomes: American Heart Association Initiatives in Action for Consumers and Patients (2009) (19)
Cangrelor Use in Cardiogenic Shock: A Single-Center Real-World Experience. (2017) (19)
Percutaneous Coronary Intervention) (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Cardiology/American Heart Association Task Force on Practice Guidelines Intervention—Summary Article: A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary (2006) (19)
Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing. (1991) (19)
Coronary sinus occlusion pressure and its relation to intracardiac pressure. (1985) (19)
Regional circulatory response to converting-enzyme inhibition in congestive heart failure. (1982) (19)
Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing (2005) (18)
Percutaneous Coronary Intervention in the Current Era Compared With 1985 – 1986 (2000) (17)
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry. (2011) (17)
Identifying the predictors of restenosis. Do we need new glasses? (1997) (17)
Multi-vessel coronary disease and percutaneous coronary intervention (2004) (17)
Detection of intracoronary fibrin degradation after coronary balloon angioplasty. (1991) (16)
Antecedent angina: a predictor of residual stenosis after thrombolytic therapy. (1989) (16)
The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade. (1985) (16)
Effect of renin-angiotensin system on limb circulation in normal subjects. (1984) (16)
Very late stent thrombosis and late target lesion revascularization: no end in sight. (2012) (16)
Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). (2012) (16)
Ureteral obstruction from Hodgkin's disease. (1974) (15)
Application of Echocardiography) (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Cardiology/American Heart Association Task Force on Practice Guidelines Echocardiography: Summary Article: A Report of the American College of ACC/AHA/ASE 2003 Guideline Update for the Clinical App (2006) (14)
Antiplatelet therapy in populations at high risk of atherothrombosis. (2006) (14)
Coronary artery disease in patients with Buerger's disease. (2005) (14)
Facilitated percutaneous coronary intervention. (2006) (13)
AHA journals lead with definitive new online site. (1998) (13)
Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty. (1991) (13)
Predicting restenosis: bigger is better but not best. (2000) (13)
The role of the extracellular matrix in arterial remodelling. (1997) (12)
Task Force 4: The relationship between cardiovascular specialists and generalists. (1994) (12)
(Committee on the Management of Patients With Chronic Stable Angina) Cardiology/American Heart Association Task Force on Practice Guidelines Stable Angina—Summary Article: A Report of the American College of ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic (2008) (12)
17th Bethesda conference: Adult cardiology training. Task Force III. Training in cardiac catheterization. (1986) (12)
Coronary interventions and their impact on post myocardial infarction survival (2005) (12)
Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. (2008) (12)
Microwave balloon angioplasty effectively seals arterial dissections in an atherosclerotic rabbit model. (1994) (12)
Can BRIGHT restore the glow of bivalirudin? (2015) (11)
Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2017) (11)
ABC's of coronary angioplasty: have we simplified it too much? Interventional Cardiology Committee, Society for Cardiac Angiography and Interventions. (1992) (11)
Abstract 2654: Major Bleeding in Patients with Acute Coronary Syndrome Undergoing Early Invasive Management Can Be Reduced by Fondaparinux, Even in the Context of Trans-Radial Coronary Intervention: Insights from OASIS-5 Trial (2006) (11)
Value of visual versus central quantitative measurements of angiographic success after percutaneous transluminal coronary angioplasty. NHLBI PTCA Registry Investigators. (1996) (11)
Nonfinancial incentives for quality: a policy statement from the American Heart Association. (2007) (11)
Cardiovascular Registries: Too Much of Good Thing? (2016) (11)
Review Article: Examining Treatment of ST-Elevation Myocardial Infarction: The Importance of Early Intervention (2010) (10)
Remodelling and restenosis: insights from animal studies. (1997) (10)
Systemic Drug Therapy for Restenosis (2002) (10)
Antiplatelet therapy: Cangrelor for ACS—lessons from the CHAMPION trials (2010) (10)
Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization? (2010) (10)
Transcatheter aortic valve replacement: history and current status. (2013) (10)
Establishing A Contemporary Training Curriculum for the Next Generation of Interventional Cardiology Fellows. (2017) (10)
Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial). (2007) (9)
ACE inhibition for the failing heart: experience with captopril. (1988) (9)
Csi-A New Approach to Interventional Cardiology (1986) (9)
The effect of antiplatelet therapy on platelet accumulation after experimental angioplasty in the rabbit iliac model. (1992) (9)
Beta-blocker therapy and primary angioplasty: what is the controversy? (2004) (9)
Restenosis: do we need to understand it to treat it? (2002) (8)
How to Manage Antiplatelet Therapy for Stenting in a Patient Requiring Oral Anticoagulants (2013) (8)
Prevention of intravenous contrast-induced nephropathy in hospital inpatients. (2008) (8)
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease (2021) (8)
Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention (2012) (8)
The Hemodynamic Consequences of Coronary Sinus Occlusion (1984) (8)
Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes (2021) (7)
Assessing Appropriateness of Coronary Angiography: Another Step in Improving Quality (2008) (7)
Percutaneous coronary intervention in women. (2003) (7)
Restenosis: A Guide to Therapy (2001) (7)
Coronary sinus occlusion: effect on ischemic left ventricular dysfunction and reactive hyperemia. (1991) (7)
The cost implications of an early versus delayed invasive strategy in acute coronary syndromes: the TIMACS study (2014) (7)
918-19 The Effect of Preprocedural Intracoronary Thrombus on Patient Outcome After Percutaneous Coronary Intervention (1995) (7)
American Heart Association Mentoring Handbook. (2003) (7)
The Effect of Pressure Controlled Intermittent Coronary Sinus Occlusion During Ischemia (1984) (6)
Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease (2018) (6)
Primary angioplasty--enduring the test of time. (1999) (6)
Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction. (2008) (6)
Evaluation for Noncardiac Surgery) (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Cardiology/American Heart Association Task Force on Practice Guidelines Noncardiac Surgery—Executive Summary A Report of the American College of ACC/AHA Guideline Update for Perioperative Card (2008) (6)
Tin ethyl etiopurpurin significantly inhibits vascular smooth muscle cell proliferation in vivo. (1996) (6)
Circulation: Cardiovascular Interventions: The First 10 Years. (2018) (6)
Percutaneous coronary angioplasty in stable and unstable angina. (1991) (5)
The changing face of coronary artery spasm: a decade of experience. (1988) (5)
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. (2022) (5)
Design of comparative clinical studies of percutaneous transluminal coronary angioplasty using estimates from the Coronary Artery Surgery Study. (1984) (5)
Case report of a coronary anomaly: crossing obtuse marginal arteries. (1991) (5)
Determinants of a successful percutaneous transluminal coronary angioplasty (NHLBI-PTCA registry) (1982) (5)
Current anticoagulation options in percutaneous intervention: designing patient-specific strategies. (2002) (5)
Coronary sinus assessment of left ventricular pressure in man (1983) (5)
Low Molecular Weight Heparin in Prevention of Restenosis After Angioplasty (2005) (5)
Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention. (2005) (5)
Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group (1996) (5)
Long‐term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting (2017) (5)
Antiplatelet therapy for postdischarge medical management of acute coronary syndrome. (2008) (5)
The “stack perfusion catheter” improves outcome following dissection during coronary angioplasty (1990) (5)
Is five-year mortality different for treatment by choice vs. random assignment in the bypass angioplasty revascularization investigation (BARI)? (1996) (5)
Coronary venous interventions: failed strategy or inadequately explored? (2015) (5)
The effect of pressure controlled intermittent coronary sinus occlusion during reperfusion (1986) (4)
Summarizing Statement of the Panel of Working Groups (1984) (4)
Update on radiation for restenosis. (2002) (4)
Women are like men ... Sometimes. (2009) (4)
Strategies to improve early reperfusion in ST-elevation myocardial infarction. (2007) (4)
THIN VERSUS THICK STRUT STENT FOR PERCUTANEOUS CORONARY INTERVENTION USING BARE METAL STENTS: INSIGHTS FROM THE NHLBI PCI DYNAMIC REGISTRY (2010) (4)
The ARTISTIC and ARREST trials. (2000) (4)
Abstract 4602: Complete Revascularization in Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Meta Analysis (2009) (4)
AHA journals lead with definitive new online site. (1998) (4)
Current status of percutaneous transluminal coronary angioplasty. (1994) (4)
Induction of Acidic Fibroblast Growth Factor and Full-Length Platelet-Derived Growth Factor Expression in Human Cardiac Allografts : Analysis by PCR , In Situ Hybridization , and Immunohistochemistry (2005) (4)
Restenosis after Angioplasty: What Have We Learned from Clinical Trials? (1993) (4)
Long-term clinical follow-up of patients successfully treated with a perfusion balloon catheter for coronary angioplasty-induced dissections or abrupt closure. (1994) (4)
Incidence and significance of mitral regurgitation following first myocardial infarction treated with rt-PA: Results fron TIMI II (1991) (4)
GEOMETRIC REMODELING. AUTHORS' REPLY (1995) (4)
Revascularization of Left Main Coronary Artery Disease (2011) (3)
Acronyms in angioplasty and restenosis: a summary of recent and ongoing clinical randomized trials. (1992) (3)
Myocardial revascularization in 1997: angioplasty versus bypass surgery. (1997) (3)
Inadequacy of current criteria for predicting high risk coronary angioplasty (1990) (3)
Best of the AHA Scientific Sessions 2009 (2009) (3)
Remodelling: historical perspectives and definition of terms. (1997) (3)
Development of a Transfemorally Delivered Endovascular Graft for Treatment of Aortic Aneurysms in a Canine Model (1997) (3)
and Interventions, and Society of Thoracic Surgeons of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography Endorsed by the Society Management of Patients With Valvular Heart Disease) Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the American College of (2009) (3)
The BIOSOLVE II trial: a step forward for the bioresorbable scaffold? (2016) (3)
Changes in medical publishing: the challenges for an interventional journal. (2013) (3)
The effect of verapamil on coponapy and systemic hemodynamics in patients with coponapy heart disease (1982) (3)
Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome? (2018) (3)
Current status of coronary angioplasty. (1987) (3)
Transcatheter aortic valve implantation: coming of age. (2011) (3)
Amending a dogma. (2018) (3)
Serial angiographic evidence of rapid resolution of coronary artery stenosis. (1983) (3)
Thrombolytic therapy versus primary angioplasty. Which offers the best outcome after myocardial infarction? (1997) (2)
The CHARISMA trial and the REACH registry outcomes. (2006) (2)
Impact of Crossover: A Consideration for Initial Access Site Selection. (2021) (2)
Probing the frontiers of angioplasty. (1989) (2)
Effect of arginine vasopressin on coronary and systemic hemodynamics in man. (1989) (2)
Early invasive versus conservative strategy for non-infarct related artery lesions in ST elevation myocardial infarction with multi-vessel disease (2015) (2)
A normal coronary angiogram: is it therapeutic? (1983) (2)
Abstract 4211: No Long Term Clinical Benefit of IVUS Guided PCI: Results From the NHLBI Dynamic Registry (2009) (2)
STAINLESS STEEL VERSUS NON-STAINLESS STEEL STENTS FOR PERCUTANEOUS CORONARY INTERVENTION USING BARE METAL STENTS: FINDINGS FROM THE NHLBI PCI DYNAMIC REGISTRY (2010) (2)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1991. A 67-year-old man with a ventricular septal defect and progressive dyspnea. (1991) (2)
Balanced Adoption of Radial Artery Access for Primary Percutaneous Coronary Intervention. (2017) (2)
Task force 5: Expert testimony and opinions. (2004) (2)
Clinical experience with percutaneous brachial coronary angiography in a "Judkins" laboratory. (1990) (2)
Acute and chronic effects of transluminal angioplasty in experimental atheroscierosis (1981) (2)
Laser thermal angioplasty: from the experimental model to early human experience. (1987) (2)
Report of the international working group on coronary sinus interventions (1986) (2)
Medical management of coronary artery disease after angioplasty and thrombolytic therapy. (1994) (2)
Challenges for the Basis of Practice The Role of Digoxin in the Treatment of Heart Failure (2008) (2)
Remodeling and plaque formation in restenosis: Effects of colchicine and enoxaparin in the atherosclerotic rabbit (1996) (2)
TECHNOLOGY AND PRACTICE EXECUTIVE COMMITTEE (1998) (2)
ACCF/AHA/SCAI CLINICAL COMPETENCE STATEMENT (2007) (2)
Patients. Current State of ST-Elevation Myocardial Infarction Care Development of Systems of Care for ST-Elevation Myocardial Infarction (2007) (2)
Revascularization in diabetes: have stents made a difference? (2002) (1)
Geometric remodeling. (1995) (1)
Cardiology/American Heart Association Task Force on Practice Guidelines on Infective Endocarditis. A Report of the American College of ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update (2008) (1)
The altered baroreceptor response to nitroglycerin in congestive heart failure (1980) (1)
Absorb Bioresorbable Scaffolds-Out of the Woods After 3 Years? (2019) (1)
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits Part 1 - Health Benefits (2006) (1)
Determinants of survival and clinical response in heart failure patients treated with captopril (1982) (1)
Quantitative Measurements of Angiographic Success After Percutaneous Transluminal Coronary Angioplasty (1996) (1)
Current Status and Future Directions in Coronary Disease and Valvular Heart Disease (2016) (1)
Angioplasty for acute myocardial infarction in community hospital without surgical back-up: response to Wharton and Angelini publications "should guidelines be changed?: not whether but when". (2000) (1)
New data on early management of patients with ST-elevation myocardial infarction (2008) (1)
Coronary Artery Compression Caused by a Large Pseudoaneurysm Complicating an Acute Myocardial Infarction (2004) (1)
Is Primary Angioplasty the Best Treatment for AMI in the Elderly? (1999) (1)
Microwave balloon angioplasty to treat arterial dissections in an atherosclerotic rabbit model (1991) (1)
International Working Group on Coronary Sinus Interventions (1986) (1)
Case 12-1991 (1991) (1)
2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention (2014) (1)
Biodegradable stents: are they finally here? (2001) (1)
Vascular disease independently predicts worse outcome after percutaneous coronary intervention: Results from the NHLBI dynamic registry (2003) (1)
Clinics of Csi: Proceedings of the 2nd International Symposium on Myocardial Protection Via the Coronary Sinus Vienna, February 2Nd-5Th, 1986 (1986) (1)
Management of unstable angina: integrating the new approaches. (2000) (1)
Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial. (2021) (1)
Acute and Chronic Effects of Transluminal Angioplasty in Three Models of Experimental Atherosclerosis (1982) (1)
Cangrelor for ACS—lessons from the CHAMPION trials (2010) (1)
Therapeutic angiogenesis. (2000) (1)
Variability in the use of invasive services: sign of poor quality of care or an opportunity to improve care? (2014) (0)
Stenting plus abciximab vs tPA in acute myocardial infarction. (2001) (0)
The great taboo of non-infarct-related artery revascularization during primary percutaneous coronary intervention. (2013) (0)
captopril . congestive heart failure treated with response to exercise in patients with Haemodynamic and neurohumoral (0)
Do coronary risk factors influence lesion morphology? A report from the 1985–1986 NHLBI PTCA registry (1991) (0)
SLIDING HIATAL HERNIA MASQUERADING AS A LEFT ATRIAL MYXOMA: ADVANTAGES OF MULTI-MODALITY IMAGING (2019) (0)
Abstract 913: Persistent High Risk of Death and Myocardial Infarction in Patients with Peripheral Arterial Disease Undergoing PCI: Results from the NHLBI Dynamic Registry (2008) (0)
Pharmacologic Perspectives of Remodeling Inhibition (1997) (0)
ACC expert consensus document on ethical coding and billing practices for cardiovascular medicine specialists11“Ethical Coding and Billing Practices for Cardiovascular Medicine Specialists” was approved by the American College of Cardiology Board of Trustees on October 24, 1998. (1999) (0)
Does prior restenosis identify patients with a higher restenosis rate when undergoing subsequent PTCA of a new lesion (1990) (0)
Abstract 18720: The Impact of Prolonged Clopidogrel Use Beyond 12 Months After Coronary Stenting in Smokers and Non-smokers (2014) (0)
Best Revascularization Strategies in Patients With CKD and DM: Still Uncertain. (2019) (0)
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. (2000) (0)
Challenges for the Basis of Practice Should We Use Outpatient Dobutamine or Milrinone (2009) (0)
Treatment ofChronic Orthostatic Hypotension withErgotamine (1983) (0)
Impaired utilization of coronary vascular reserve in hypercholesterolehic swine (1991) (0)
Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock. (2017) (0)
AHA journals lead with definitive new online site. (1998) (0)
Acute Myocardial Infarction ( AMI ) Advisory Primary Percutaneous Coronary Intervention ST-Segment – Elevation Myocardial Infarction Patients With Timely (2006) (0)
A new series: Clinical Dilemmas in Interventional Cardiology. (2013) (0)
Advances in Cardiopulmonary Resuscitation (0)
MECHANISMS OF LATE STENT THROMBOSIS AND VERY LATE STENT THROMBOSIS (2012) (0)
Abstract 4729: Bare Metal vs. Drug-Eluting Stents for Calcified Lesion: Findings From the NHLBI PCI Dynamic Registry (2009) (0)
Patients: Executive Summary Development of Systems of Care for ST-Elevation Myocardial Infarction (2008) (0)
Synchronized Coronary Venous Retroperfusion During Coronary Angioplasty (1991) (0)
680 Do patients with type 2 diabetes and stable coronary artery disease with or without angina have a similar prognosis? a sub-study of the bari 2D trial (2011) (0)
The many costs of bleeding. (2009) (0)
Myocyte Protection by Pharmacological Therapy (2008) (0)
A synthetic chlorin derivative, tin ethyl etiopurpurin, inhibits smooth muscle cell proliferation without light activation (1996) (0)
Angiotensin converting enzyme inhibition in the prevention of restenosis: the MERCATOR and MARCATOR trials (1993) (0)
2008 Writing Group to Review New Evidence and Update the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease, Writing on Behalf of the 2006 Valvular Heart Disease Writing Committee (2008) (0)
Oral Anticoagulant Alone for Patients With AF and a Prior Stent: Is Less Always Best? (2021) (0)
Where Has All the Coronary Artery Spasm Gone (1990) (0)
Irish cardiac society (1990) (0)
Development of a Pharmacy Resident-Run Transitions of Care Service in a High-Risk Cardiovascular Patient Population (2018) (0)
Welcome to Reviews in Cardiovascular Medicine (2019) (0)
Summary statement — PICSO (1986) (0)
Can β-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction? (2004) (0)
Abstract 4297: The Impact of Vascular Complications and Advanced Age on Outcomes Following Percutaneous Coronary Intervention (2009) (0)
Erratum: ACC/AHA/SCAI/AMAConvened PCPI/ NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention (Journal of the American College of Cardiology (2014) 63 (722-745) doi:10.1016/j.jacc.2013.12.003) (2014) (0)
Can beta-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction? (2004) (0)
Antithrombotic agents. Fondaparinux in acute coronary syndromes: improved efficacy and safety. (2006) (0)
AHA journals lead with definitive new online site. (1998) (0)
Coronary Angioplasty: Present Status and Future Directions (1989) (0)
Abstract 13013: The Impact of Prolonged Clopidogrel Beyond 12 Months After Coronary Stenting in Patients with Acute Coronary Syndromes (2014) (0)
1138-63 The impact of ejection fraction on long-term mortality after revascularization in patients with congestive heart failure: A report from the BARI trial (2004) (0)
Native and Prosthetic Valve Stenosis (2014) (0)
Abstract 16391: The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention - Insights From the CURRENT-OASIS 7 Trial (2016) (0)
Altenlase for stroke. Authors' reply (2002) (0)
Cardiac rupture after myocardial infarction treated with tissue plasminogen activator: Results fron TIMI-II (1991) (0)
Revascularization in Diabetics, Lessons from the BARI Trial (1998) (0)
Coronary Spasm—Clinical and Angiographic Observations (1989) (0)
The influence of coronary collaterals on the long term outcome of patients after unsucessful PICA a report from the 1985–1986, NHLBI PTCA registry (1991) (0)
Abstract 16033: Prolonged Use of Clopidogrel and Risk of Death, Myocardial Infarction, and Major Bleeding 5 Years after Coronary Stenting in VA Patients with Chronic Kidney Disease (2012) (0)
Abstract 4695: Complete Revascularization versus Culprit-only Revascularization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Meta-Analysis (2009) (0)
Abstract 19782: Is Multivessel Revascularization in Patients with ST-Segment Myocardial Infarction Associated with Increased Risk of Acute Complications? Insights from the NHLBI PCI Dynamic Registry (2010) (0)
INTERVENTIONAL CARDIOLOGY (2019) (0)
The impact of interventional techniques on the practice of cardiology. (1989) (0)
What is the Effect of Arginine Vasopressin on Coronary and Systemic Vascular Tone in Man (1989) (0)
Effect of intracoronary acetylcholine infusion on coronary diameter in hypertensive patients with angina (1990) (0)
PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN ARTERY STENOSIS Early Experience (2011) (0)
Edinburgh Research Explorer Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2017) (0)
Alteplase for stroke [1] (multiple letters) (2002) (0)
The therapeutic and economic impact of normal coronary arteriograms in patients with severe chest pain (1981) (0)
Hemodynamic Characterization of Angiodilation Therapy in Atherosclerotic Vasculogenic Impotence (1987) (0)
Alteplase for stroke. American Heart Association explains how guidelines were formulated. (2002) (0)
Management of acute angioplasty complications (1996) (0)
Best of TCT 2005 (0)
Improving Quality of Care Through Disease Management Principles and Recommendations From the American Heart Association’s Expert Panel on Disease Management AHA (2004) (0)
Outcome after a Third Coronary Angioplasty for Recurrent Native Coronary Artery Restenosis (1990) (0)
Abstract 10908: Bare Metal Stents, Durable Polymer Drug Eluting Stents or Biodegradable Polymer Stents for Coronary Artery Disease: A Mixed Treatment Comparison Analysis of 254 361 Patient-Years of Follow-up From Randomized Trials (2013) (0)
Efficacy of beta-blocker usage post-percutaneous coronary intervention (2006) (0)
Women Versus Men Regarding Outcome of CABG or PTCA Response (1999) (0)
Tailored Antiplatelet Therapy in Patients Undergoing PCI (2020) (0)
Angioplasty, Laser Probes and Atherectomy (1990) (0)
Coronary Angioplasty (2005) (0)
Multivessel PCI: pros and cons of staged procedures (2001) (0)
Pros and cons of coronary sinus interventions versus conventional therapy (1986) (0)
Post-Percutaneous Coronary Intervention Discharge Against Medical Advice: Infrequent But Deadly. (2018) (0)
Does low dose intracororary rt-PA lyse chronic thrombotic occlusions prior to PTCA? (1990) (0)
Late-Breaking Trial Results Presented in Stockholm (2019) (0)
Critical GI issues for the cardiologist: new insights and understanding. Introduction. (2005) (0)
IS077 Keynote Lecture : Radiation for the Treatment of Restenosis (2000) (0)
Clinical and Procedural Predictors of Recurrent Restenosis after Coronary Balloon Angioplasty (1989) (0)
Abstract 2814: Temporal Changes in the Outcomes of Patients with Diabetes Mellitus Undergoing PCI in the NHLBI Dynamic Registry (2006) (0)
A statistical model to predict risk for hemodynamic compromise during coronary angioplasty (1991) (0)
Abstract 5617: Paradoxical Low Use of Coronary Interventions in High-Risk Non-st Segment Acute Coronary Syndromes with Heart Failure. Data from the Oasis-5 Randomized Trial (2008) (0)
Pros and cons — coronary sinus intervention vs. conventional therapy (1986) (0)
Restenosis after angioplasty: have we been aiming at the wrong target? (1994) (0)
CO-INVESTIGATORS OF THE NATICJNAL HEARI-, Lc~G, ,AND Skoa~ TNSTITUTE PERCUTAPEO~~S THANSLUMINAL CORONARY AN~;!c?P!..QTV REGISTRY Rrvlwster, Mimwsoto (1988) (0)
Coming of age. (2018) (0)
Role of the Cardiologist and the Generalist i Cardiovascular Preventive Care (0)
Fractional Flow Reserve: Does Sex Matter? (2019) (0)
acilitated Percutaneous Coronary Intervention (2006) (0)
1138-64 Major reduction in adverse outcomes of patients with congestive heart failure undergoing percutaneous coronary intervention: A comparison of the National Heart, Lung, and Blood Institute 1985–1986 percutaneous transluminal coronary angioplasty registry and the current dynamic registry (2004) (0)
Asissment of intracoronary fibrin metabolism after coronary angioplasty in man (1990) (0)
Abstract 4605: Prolonged Use of Clopidogrel Reduces Death and Myocardial Infarction Following Drug Eluting Stent but Not Bare Metal Stent Placement: The VA DES Study (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David P. Faxon?

David P. Faxon is affiliated with the following schools: